RxDoctor Payments Data

Scott Ball, MD

Orthopaedic Surgery · San Diego, CANPI 1952325318

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $267,058 of the $368,462 with a category attached, or 72.5%. 9 manufacturers reported payments, led by Restor3d, Inc. at 57.5% of the total. Reporting peaked in 2024 at $202,824 and has fallen 77.2% since, to $46,203 in 2025. Among orthopaedic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$368,462in general payments, 2019–2025

Across 227 payments — averaging $1623.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Restor3d, Inc.$212K
  • Conformis, Inc.$105K
  • Orthalign Inc$31K
  • Medical Device Business Services, Inc.$13K
  • Biocomposites Inc$4K
  • Pacira Therapeutics, Inc.$3K
  • plus $1K from 3 others
$38,406in research payments, 2019–2025

Across 10 payments — averaging $3840.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Conformis, Inc.$35K
  • Medical Device Business Services, Inc.$4K

What the payments were for

  • Royalty or licence$23,8176%
  • Consulting fees$267,05872%
  • Speaking & faculty fees$44,10012%
  • Travel & lodging$24,2727%
  • Food & beverage$9,2153%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$368,462 in reported general payments places this provider in the 95th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California →

Medicare billing

Part B allowed, 2024
$469,570
Medicare patients
544
Services billed
1,206

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin16$28
Dexamethasone20$28

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in San Diego

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →